Filtros de búsqueda

Lista de obras de Gilles Salles

90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.

artículo científico publicado en 2013

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patient

artículo científico publicado en 2012

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

artículo científico publicado en 2018

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

artículo científico publicado en 2015

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies.

artículo científico publicado en 2018

A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders

artículo científico publicado en 2014

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

artículo científico publicado en 2018

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

artículo científico publicado en 2017

Abstract LB-272: Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

artículo científico publicado en 2016

Administration of anticancer drugs: exposure in hospital nurses.

artículo científico publicado en 2014

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

scientific article published on 01 August 2018

Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.

artículo científico publicado en 2005

Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.

artículo científico publicado en 2012

Are we nearing an era of chemotherapy-free management of indolent lymphoma?

artículo científico publicado en 2014

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders

artículo científico publicado en 2016

Authors' Reply

scientific article published on 01 March 2018

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.

artículo científico publicado en 2013

Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.

artículo científico publicado en 2018

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

scientific article published on 01 March 2020

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

artículo científico publicado en 2016

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

scientific article published on 15 April 2013

CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma

artículo científico publicado en 2011

CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment

artículo científico publicado en 2015

CD1d-restricted peripheral T cell lymphoma in mice and humans

artículo científico publicado en 2016

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases

artículo científico publicado en 2009

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.

artículo científico publicado en 2012

Case report: Purulent transformation of granulocytic sarcoma: An unusual pattern of differentiation in acute promyelocytic leukemia.

artículo científico publicado en 2018

Cat-Scratch Disease: A Pitfall for Lymphoma Evaluation by FDG-PET/CT.

artículo científico publicado en 2016

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

artículo científico publicado en 2018

Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic management.

artículo científico publicado en 2014

Chronic Borrelia burgdorferi infection triggers NKT lymphomagenesis

artículo científico publicado en 2018

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

artículo científico publicado en 2021

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era

scientific article published on 30 January 2020

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.

artículo científico publicado en 2012

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis

artículo científico publicado en 2006

Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?

artículo científico publicado en 2005

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma

artículo científico publicado en 2020

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.

artículo científico publicado en 2016

Comparison study for genotyping of a single-nucleotide polymorphism in the tumor necrosis factor promoter gene

artículo científico publicado en 2002

Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.

artículo científico publicado en 2012

Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases

scientific article published on 06 February 2020

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

artículo científico publicado en 2017

Current and future management of follicular lymphoma.

artículo científico

Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.

artículo científico publicado en 2013

Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma

artículo científico publicado en 2007

Development of model for analysing respective collections of intended hematopoietic stem cells and harvests of unintended mature cells in apheresis for autologous hematopoietic stem cell collection.

artículo científico publicado en 2014

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

artículo científico publicado en 2018

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

artículo científico publicado en 2013

EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma

artículo científico publicado en 2021

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

artículo científico publicado en 2016

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

artículo científico publicado en 2016

Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.

artículo científico publicado en 2018

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma

artículo científico publicado en 2006

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.

artículo científico publicado en 2014

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma

artículo científico publicado en 2017

Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)

scientific article published on 10 April 2020

FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts

artículo científico

FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.

artículo científico publicado en 2016

FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia

scientific article published on 13 June 2018

Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients

scientific article published on 01 May 2012

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

artículo científico publicado en 2017

First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis

artículo científico publicado en 2013

From genetics to the clinic: a translational perspective on follicular lymphoma.

artículo científico publicado en 2018

Gene expression profiling of gray zone lymphoma

artículo científico publicado en 2020

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

artículo científico publicado en 2019

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

artículo científico publicado en 2019

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

artículo científico publicado en 2016

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region

artículo científico publicado en 2014

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

artículo científico publicado en 2014

Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA

scientific article published on 01 March 2019

HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.

artículo científico publicado en 2018

Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?

artículo científico publicado en 2010

Heterogeneity of acute lymphoblastic leukemia in HIV-seropositive patients ⬇️

artículo científico publicado el 1 de mayo de 1994

High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia

artículo científico publicado en 2012

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

scientific article published on 01 April 2020

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

artículo científico publicado en 2015

Human germinal center transcriptional programs are de-synchronized in B cell lymphoma

artículo científico publicado en 2018

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

artículo científico publicado en 2002

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

artículo científico publicado en 2018

Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.

artículo científico publicado en 2014

Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance

artículo científico publicado en 2010

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases

artículo científico publicado en 2013

Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma.

artículo científico publicado en 2013

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

artículo científico publicado en 2017

Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and G

artículo científico

Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.

artículo científico publicado en 2012

Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

artículo científico publicado en 2011

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia

scientific article published on 29 January 2020

In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.

artículo científico publicado en 2012

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party

artículo científico publicado en 2013

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

artículo científico publicado en 2017

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

artículo científico publicado en 2018

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study

artículo científico publicado en 2020

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study

article

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

artículo científico publicado en 2013

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.

artículo científico publicado en 2014

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

artículo científico publicado en 2017

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

scientific article published on 11 December 2019

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

artículo científico publicado en 2018

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies

artículo científico publicado en 2015

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

artículo científico publicado en 2017

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA.

artículo científico publicado en 2013

MALT lymphomas: pathogenesis can drive treatment.

artículo científico publicado en 2011

Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study

artículo científico publicado en 2018

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association

scientific article published on 06 October 2016

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management

article

MicroRNA expression profile in splenic marginal zone lymphoma

artículo científico publicado en 2011

Monitoring NK cell activity in patients with hematological malignancies.

artículo científico publicado en 2013

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.

artículo científico publicado en 2012

New Agents to Treat Chronic Lymphocytic Leukemia.

artículo científico publicado en 2016

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2014

Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma

artículo científico publicado en 2012

Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study.

artículo científico publicado en 2013

Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study.

artículo científico publicado en 2013

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).

artículo científico publicado en 2013

Obinutuzumab for chronic lymphocytic leukemia.

artículo científico publicado en 2014

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study

artículo científico publicado en 2018

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

artículo científico publicado en 2016

One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy.

artículo científico publicado en 2018

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study

artículo científico publicado en 2018

PET-CT and diagnostic CT: the synergy of metabolic and morphological data in onco-haematology

artículo científico publicado en 2013

PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study

artículo científico

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

artículo científico publicado en 2014

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.

artículo científico publicado en 2013

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2015

Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase

artículo científico publicado en 2014

Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients.

artículo científico publicado en 2012

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

artículo científico publicado en 2012

Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma

scientific article published on 02 January 2019

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index

artículo científico publicado en 2010

Predictive gene-expression score for follicular lymphoma - Authors' reply

artículo científico publicado en 2018

Predictors of prescription errors involving anticancer chemotherapy agents

artículo científico publicado en 2012

Pregnancy and multiple myeloma are not antinomic.

artículo científico publicado en 2013

Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2013

Prevalence and pattern of antinuclear autoantibodies in 347 patients with non‐Hodgkin's lymphoma ⬇️

artículo científico publicado el 1 de octubre de 2003

Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.

artículo científico

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

artículo científico publicado en 2018

Rapamycin safeguards lymphocytes from DNA damage accumulation in vivo.

artículo científico publicado en 2016

Recurrent cerebral venous thrombosis revealing paraneoplastic angiitis in Hodgkin's lymphoma

artículo científico publicado en 2008

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

artículo científico publicado en 2016

Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes

artículo científico publicado en 2018

Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B‐cell lymphoma (SRPL) ⬇️

artículo científico publicado el 1 de marzo de 2011

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

artículo científico

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

artículo científico publicado en 2016

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

artículo científico publicado en 2017

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

scientific article published on 04 July 2018

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

artículo científico publicado en 2017

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

artículo científico publicado en 2017

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up

artículo científico publicado en 2012

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

artículo científico publicado en 2010

Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma

artículo científico publicado en 2014

Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma

artículo científico publicado en 2012

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

artículo científico publicado en 2018

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

artículo científico publicado en 2013

Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers

artículo científico publicado en 2017

Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm

artículo científico publicado en 2012

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

artículo científico publicado en 2011

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

scientific article published on 14 February 2020

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

scientific article published on 19 November 2019

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

artículo científico publicado en 2003

Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.

artículo científico publicado en 2016

Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity

artículo científico publicado en 2012

Splenic marginal zone lymphoma: current knowledge and future directions.

artículo científico publicado en 2012

Splenic marginal-zone lymphoma: a distinct clinical and pathological entity

artículo científico publicado en 2003

Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?

artículo científico publicado en 2007

Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors era

artículo científico publicado en 2018

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

artículo científico publicado en 2011

Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma

artículo científico publicado en 2014

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA

artículo científico publicado en 2012

Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas

artículo científico publicado en 2016

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

artículo científico publicado en 2016

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

artículo científico publicado en 2015

The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: Application to chronic lymphocytic leukemia.

artículo científico publicado en 2016

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

artículo científico

Through the Glass Ceiling.

artículo científico publicado en 2018

Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.

artículo científico publicado en 2018

Treatment approaches to asymptomatic follicular lymphoma

artículo científico publicado en 2013

Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience

artículo científico publicado en 2016

Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort

artículo científico publicado en 2019

Use of Commercial anti-CD19 CAR T Cell Therapy for Patients with Relapsed/Refractory Aggressive B Cell Lymphoma in a European center

artículo científico publicado en 2020

Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL

artículo científico publicado en 2018

Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study

artículo científico publicado en 2018

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life

artículo científico publicado en 2018

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.

artículo científico publicado en 2018

What is the best first-line treatment strategy for patients with indolent lymphomas?

artículo científico publicado en 2012

[The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas]

artículo científico publicado en 2005

[The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas]

scientific article published on 01 January 2005

t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

µ-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis.

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda